First Trust NYSE Arca Biotechnology UCITS ETFFirst Trust NYSE Arca Biotechnology UCITS ETFFirst Trust NYSE Arca Biotechnology UCITS ETF

First Trust NYSE Arca Biotechnology UCITS ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪8.86 M‬EUR
Fund flows (1Y)
‪4.84 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−0.10%
Shares outstanding
‪448.87 K‬
Expense ratio
0.60%

About First Trust NYSE Arca Biotechnology UCITS ETF


Issuer
AJM Ventures LLC
Brand
First Trust
Inception date
May 27, 2020
Structure
Irish VCIC
Index tracked
NYSE Arca Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
First Trust Global Portfolios Ltd.
ISIN
IE00BL0L0H60
The Fund seeks investment results that correspond generally to the price and yield (before the Funds fees

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 26, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.96%
Health Technology96.41%
Health Services3.55%
Bonds, Cash & Other0.04%
Cash0.04%
Stock breakdown by region
83%16%
North America83.30%
Europe16.70%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


FBT invests in stocks. The fund's major sectors are Health Technology, with 96.41% stocks, and Health Services, with 3.55% of the basket. The assets are mostly located in the North America region.
FBT top holdings are ACADIA Pharmaceuticals Inc. and Neurocrine Biosciences, Inc., occupying 4.77% and 4.36% of the portfolio correspondingly.
FBT assets under management is ‪8.86 M‬ EUR. It's risen 26.14% over the last month.
FBT fund flows account for ‪4.84 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, FBT doesn't pay dividends to its holders.
FBT shares are issued by AJM Ventures LLC under the brand First Trust. The ETF was launched on May 27, 2020, and its management style is Passive.
FBT expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
FBT follows the NYSE Arca Biotechnology Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
FBT invests in stocks.
FBT price has fallen by −3.75% over the last month, and its yearly performance shows a −4.36% decrease. See more dynamics on FBT price chart.
NAV returns, another gauge of an ETF dynamics, have fallen by −1.55% over the last month, showed a −8.98% decrease in three-month performance and has decreased by −4.36% in a year.
FBT trades at a premium (0.10%) meaning the ETF is trading at a higher price than the calculated NAV.